EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Troxerutin Potentiated Temozolomide Induced Antitumor Effect in 2D and 3D Glioblastoma Models

Deborah Mannino, Elsa Calcaterra, Sarah Adriana Scuderi, Maria Caffo, Fabiola De Luca, Antonio Catalfamo, Giovanna Casili, Irene Paterniti

Journal of Cellular and Molecular Medicine · 2025

DOI: 10.1111/jcmm.70862 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Deborah Mannino und 7 weiteren Autor:innen. Beteiligte Einrichtung: Research Operative Unit of Neuropharmacology and Translational Neurosciences, Oasi Research Institute, Troina, Italy. Hauptthemen laut MEDLINE: Temozolomide, Hydroxyethylrutoside, Glioblastoma, Brain Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) is a highly aggressive brain tumour characterised by rapid proliferation and high invasiveness. Temozolomide (TMZ) is the first‐line chemotherapy, but its efficacy is often compromised by intrinsic or acquired resistance and significant side effects. Recent studies have demonstrated that combining TMZ with natural compounds can enhance therapeutic efficacy through synergistic mechanisms and reduce systemic toxicity. In this study, the adjuvant potential of troxerutin (TROX), a natural flavonoid present found in tea, coffee, cereals, fruits and vegetables, and known for its antioxidant and anti‐inflammatory properties, was evaluated in an in vitro model of human U87 cells. The TROX–TMZ combination showed a significant synergistic effect, effectively reducing cell viability, clonogenic capacity, migration and epithelial‐mesenchymal transition (EMT), as well as promoting apoptosis. The combined treatment also modulated oxidative stress and inflammation by activating the KEAP1/NRF2 axis, resulting in increased levels of HO‐1, GSH and SOD1, and decreased ROMO1, ROS, nitrites and pro‐inflammatory cytokines (IL‐6, TNF‐α and IL‐1β). These effects were also confirmed in three‐dimensional models (spheroids), suggesting that the combination exerts significant antitumor activity. These results indicate that TROX could represent an effective adjuvant in the treatment of GBM, providing a novel therapeutic strategy to potentiate the antitumor effects of TMZ.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TemozolomideHydroxyethylrutosideGlioblastomaBrain NeoplasmsTropoloneHumansDrug SynergismApoptosisCell Line, TumorEpithelial-Mesenchymal TransitionCell SurvivalOxidative StressCell ProliferationCell MovementSpheroids, Cellular

Stichwörter der Autor:innen

glioblastomanatural flavonoidoxidative stresstemozolomidetroxerutin

Substanzen

TemozolomideHydroxyethylrutosidetroxerutinTropolone

Autor:innen und Institutionen

  • Research Operative Unit of Neuropharmacology and Translational Neurosciences, Oasi Research Institute, Troina, Italy.
  • Department of Chemical, Biological, Pharmaceutical and Environmental Science, University of Messina, Messina, Italy.
  • Unit of Neurosurgery, Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy.

Zitieren

APA

Mannino, D., Calcaterra, E., Scuderi, S. A., Caffo, M., De Luca, F., Catalfamo, A., Casili, G., & Paterniti, I. (2025). Troxerutin Potentiated Temozolomide Induced Antitumor Effect in 2D and 3D Glioblastoma Models. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70862

Vancouver

Mannino D, Calcaterra E, Scuderi SA, Caffo M, De Luca F, Catalfamo A, et al. Troxerutin Potentiated Temozolomide Induced Antitumor Effect in 2D and 3D Glioblastoma Models. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70862

BibTeX
@article{Mannino2025,
  author = {Mannino, Deborah and Calcaterra, Elsa and Scuderi, Sarah Adriana and Caffo, Maria and De Luca, Fabiola and Catalfamo, Antonio and Casili, Giovanna and Paterniti, Irene},
  title = {Troxerutin Potentiated Temozolomide Induced Antitumor Effect in 2D and 3D Glioblastoma Models},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2025},
  doi = {10.1111/jcmm.70862}
}
Kostenlos starten →